Overview

21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus

Status:
Completed
Trial end date:
2018-03-15
Target enrollment:
Participant gender:
Summary
Single Center, Double Blind, Active Comparator Controlled 2-Way Crossover Multiple Dose Safety, Tolerability and Efficacy Study
Phase:
Phase 2
Details
Lead Sponsor:
Diasome Pharmaceuticals
Collaborator:
Integrium
Treatments:
Insulin
Insulin Lispro
Insulin, Globin Zinc